These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 7529871)
21. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035 [TBL] [Abstract][Full Text] [Related]
22. GRB2 and phospholipase C-gamma 1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation. Sieh M; Batzer A; Schlessinger J; Weiss A Mol Cell Biol; 1994 Jul; 14(7):4435-42. PubMed ID: 7516467 [TBL] [Abstract][Full Text] [Related]
23. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase. Ricci A; Lanfrancone L; Chiari R; Belardo G; Pertica C; Natali PG; Pelicci PG; Segatto O Oncogene; 1995 Oct; 11(8):1519-29. PubMed ID: 7478576 [TBL] [Abstract][Full Text] [Related]
24. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner. Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728 [TBL] [Abstract][Full Text] [Related]
25. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Zhou MM; Meadows RP; Logan TM; Yoon HS; Wade WS; Ravichandran KS; Burakoff SJ; Fesik SW Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7784-8. PubMed ID: 7544002 [TBL] [Abstract][Full Text] [Related]
26. Shc associates with an unphosphorylated form of the p21ras guanine nucleotide exchange factor mSOS. de Vries-Smits AM; Pronk GJ; Medema JP; Burgering BM; Bos JL Oncogene; 1995 Mar; 10(5):919-25. PubMed ID: 7898933 [TBL] [Abstract][Full Text] [Related]
27. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation. Waters SB; Chen D; Kao AW; Okada S; Holt KH; Pessin JE J Biol Chem; 1996 Jul; 271(30):18224-30. PubMed ID: 8663461 [TBL] [Abstract][Full Text] [Related]
28. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. van der Geer P; Wiley S; Gish GD; Pawson T Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605 [TBL] [Abstract][Full Text] [Related]
29. Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association. Evans GA; Goldsmith MA; Johnston JA; Xu W; Weiler SR; Erwin R; Howard OM; Abraham RT; O'Shea JJ; Greene WC J Biol Chem; 1995 Dec; 270(48):28858-63. PubMed ID: 7499411 [TBL] [Abstract][Full Text] [Related]
30. Requirement for Shc in TCR-mediated activation of a T cell hybridoma. Pratt JC; van den Brink MR; Igras VE; Walk SF; Ravichandran KS; Burakoff SJ J Immunol; 1999 Sep; 163(5):2586-91. PubMed ID: 10452997 [TBL] [Abstract][Full Text] [Related]
31. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566 [TBL] [Abstract][Full Text] [Related]
32. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation. Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386 [TBL] [Abstract][Full Text] [Related]
33. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes. Harmer SL; DeFranco AL Mol Cell Biol; 1997 Jul; 17(7):4087-95. PubMed ID: 9199344 [TBL] [Abstract][Full Text] [Related]
34. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. Sasaoka T; Draznin B; Leitner JW; Langlois WJ; Olefsky JM J Biol Chem; 1994 Apr; 269(14):10734-8. PubMed ID: 8144662 [TBL] [Abstract][Full Text] [Related]
35. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588 [TBL] [Abstract][Full Text] [Related]
36. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. Prigent SA; Nagane M; Lin H; Huvar I; Boss GR; Feramisco JR; Cavenee WK; Huang HS J Biol Chem; 1996 Oct; 271(41):25639-45. PubMed ID: 8810340 [TBL] [Abstract][Full Text] [Related]
37. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase. Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290 [TBL] [Abstract][Full Text] [Related]
38. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites. Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530 [TBL] [Abstract][Full Text] [Related]
39. Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc. Liu L; Damen JE; Cutler RL; Krystal G Mol Cell Biol; 1994 Oct; 14(10):6926-35. PubMed ID: 7523859 [TBL] [Abstract][Full Text] [Related]
40. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Pruett W; Yuan Y; Rose E; Batzer AG; Harada N; Skolnik EY Mol Cell Biol; 1995 Mar; 15(3):1778-85. PubMed ID: 7862167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]